I’m 65, widowed and collecting Social Security survivor benefits. Should I claim my own benefits now?
“I am concerned that benefits could be reduced or even discontinued if Social Security runs out of money in the coming years.”
Oil prices surge as fresh attacks threaten the cease-fire with Iran
U.S. stock-index futures swung back for forth Sunday, after a massive tech selloff on Friday interrupted Wall Street’s two-month rally, and after new developments threatened the fragile cease-fire in the Iran war.
Nvidia strikes a new memory-chip deal — but SK Hynix and Samsung shares are under heavy pressure
South Korea’s once-hot Kospi index is headed for another day of sharp declines as the AI trade loses steam.
S&P 500 companies can’t stop talking about higher oil prices. But few say they’ll actually hurt profits.
Only seven companies cited oil prices as a reason for cutting or not updating their profit outlooks for the year.
These are the market’s new hot stocks as investors flee from tech
Investors are suddenly dumping technology stocks and rotating into other areas — including health insurers, banks and retailers.
Access Denied
Access Denied You don’t have permission to access ” on this server. Reference #18.162c1102.1780844817.4ae0b0d4
‘He’s taking advantage of me’: My husband won’t sell his home so we can combine our finances and live in comfort. Am I unreasonable?
“Our homes are 20 miles apart, and he still drives back and forth almost daily.”
‘This would be a one-time event’: How can I take extra money from my 401(k) without triggering higher Medicare premiums?
“I generally withdraw money from my traditional 401(k) for projects, larger expenses and sometimes just to stay ahead on upcoming bills.”
‘No one wears bling’: What does it say about America if people are afraid to wear their jewelry?
“I’ve been to many shows, operas, big parties and fundraisers.”
Tired of nausea or taking a GLP-1 pill every day? These experimental drugs could be better than Zepbound and Wegovy.
There is a new wave of weight-loss therapies in development that aim to be better than the existing GLP-1s.
